Tango Therapeutics, Inc. Stock Performance

Open $23.38	Prev. Close $23.48	Circuit Range N/A
Day Range $21.73 - $23.38	Year Range $6.69 - $34.35	Volume 1,42,364
Average Traded $22.12

Tango Therapeutics, Inc. Share Price Today

As of 19 September 2026, Tango Therapeutics, Inc.'s share price is $21.76. The stock opened at $23.38, compared to its previous close of $23.48. During today's trading session, Tango Therapeutics, Inc.'s share price traded between $21.73 and $23.38, with an average price of $22.55. Over the past 52 weeks, the stock has recorded a high of $34.35 and a low of $6.69. In terms of performance, Tango Therapeutics, Inc.'s share price has risen by 3.97% over the last six months and is up 159.05% on a year-on-year basis.

Tango Therapeutics, Inc. Share Price Chart

$21.73$23.38

Tango Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap $2.53B	PE Ratio (TTM) -25.01	Dividend Yield N/A
EPS (TTM) $-0.87	Revenue (TTM) $62.38M	Return On Equity (TTM) -29.35%
Profit Margin -162.85%	Debt to Equity 0.06	Quarterly Earnings Growth YoY 154.46%

Tango Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

Particulars	Mar 2024	Jun 2024	Sep 2024	Mar 2025	Jun 2025	Sep 2025
Revenue	$6.47M	$19.88M	$11.61M	$5.39M	$3.18M	$53.81M
Net Profit	-$37.91M	-$25.55M	-$29.17M	-$39.88M	-$38.85M	$15.88M
Net Profit Margin	-585.91%	-128.56%	-251.29%	-739.54%	-1221.41%	29.52%
Income Change	N/A	32.61%	-14.15%	-36.72%	2.57%	140.88%

Tango Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars	2021	2022	2023	2024	2025
Revenue	$37.04M	$24.86M	$36.53M	$42.07M	$62.38M
Net Profit	-$58.23M	-$108.18M	-$101.74M	-$130.30M	-$101.59M
Net Profit Margin	-157.21%	-435.14%	-278.54%	-309.73%	-162.85%
Income Change	N/A	-85.76%	5.95%	-28.07%	22.03%

About Tango Therapeutics, Inc.

Tango Therapeutics, Inc., a precision oncology company, focuses on the discovery and development of drugs in defined patient populations with unmet medical need. The company develops methylthioadenosine -cooperative protein arginine methyltransferase 5 (PRMT5) inhibitors, including TNG462, which is in Phase 1/2 clinical trial for treating pancreatic and lung cancer; and TNG456, a brain-penetrant PRMT5 inhibitor for the treatment of glioblastoma. It is developing TNG260, a co-repressor of repressor element-1 silencing transcription inhibitor to reverse the immune evasion effect of serine-threonine kinase 11 loss-of-function mutations for treating lung cancer. The company was founded in 2017 and is headquartered in Boston, Massachusetts.

Tango Therapeutics, Inc. Historical Returns

Month	Open	Close	Change %
Sep 2026	$22.66	$21.75	-13.98%
Aug 2026	$26.73	$25.28	-7.06%
Jul 2026	$30.93	$27.20	-13.06%
Jun 2026	$21.54	$31.29	+42.14%
May 2026	$21.33	$22.01	+1.76%
Apr 2026	$21.04	$21.63	+3.34%
Mar 2026	$10.94	$20.93	+87.80%
Feb 2026	$11.76	$11.14	-4.17%
Jan 2026	$8.88	$11.63	+31.19%
Dec 2025	$10.65	$8.87	-18.89%
Nov 2025	$7.93	$10.93	+34.86%
Oct 2025	$8.49	$8.11	-3.51%

TNGX Share Price FAQs

What is Tango Therapeutics, Inc. share price today?

Tango Therapeutics, Inc. share price today is $21.76 as on September 19, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Tango Therapeutics, Inc. stock?

The 52 week high of Tango Therapeutics, Inc. stock is $34.35, while the 52 week low is $6.69 as of 19 Sep '26.

What is TNGX's market capitalisation today?

TNGX market capitalisation is $2.53B as of September 19, 2026, at 10:41 pm IST.

What is TNGX's net income for the last quarter?

TNGX's net income for the last quarter is 0.02B USD.

What is the 5 year returns of TNGX?

The 5 year returns of TNGX is 68.29% as on 19 Sep '26.

What is the high & low stock price of TNGX today?

TNGX stock price hit a high of $23.38 and low of $21.73 as of 19 Sep '26.

Can I buy TNGX shares in India?

Yes. You can buy TNGX in India by opening an international trading account.